These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 7964136)
41. A novel treatment for patients with hereditary haemorrhagic telangiectasia. Farnan TB; Gallagher G; Scally CM J Laryngol Otol; 2002 Oct; 116(10):849-50. PubMed ID: 12437844 [TBL] [Abstract][Full Text] [Related]
42. Nd-YAG laser photocoagulation for epistaxis associated with hereditary hemorrhagic telangiectasia. Mahoney EJ; Shapshay SM Laryngoscope; 2005 Feb; 115(2):373-5. PubMed ID: 15689770 [No Abstract] [Full Text] [Related]
43. Resurfacing the nasomaxillary cavity for management of epistaxis in Osler-Rendu-Weber disease. Bedongi A; McCombe D; Kennedy J; Morrison W J Plast Reconstr Aesthet Surg; 2006; 59(5):537-40; discussion 536. PubMed ID: 16749201 [TBL] [Abstract][Full Text] [Related]
44. Epistaxis in people with hereditary haemorrhagic telangiectasia: surgical management and psychological impact. Crouch-Smith HA; Fenn KJ; Williams SP Br J Hosp Med (Lond); 2021 Nov; 82(11):1-10. PubMed ID: 34817260 [TBL] [Abstract][Full Text] [Related]
45. Hereditary hemorrhagic telangiectasia: a new surgical approach. de Miranda DR; Lima MM; Cavalcante AL; Leite EB; Pinheiro SD; de Freitas MR Braz J Otorhinolaryngol; 2007; 73(1):135. PubMed ID: 17505615 [No Abstract] [Full Text] [Related]
55. Anaesthetic management for caesarean section in a patient with hereditary haemorrhagic telangiectasia and severe epistaxis during pregnancy. Fogang D C; Martin G; Boehlen F; Savoldelli GL BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37788916 [TBL] [Abstract][Full Text] [Related]
56. Worsening of nose bleeding heralds high cardiac output state in hereditary hemorrhagic telangiectasia. Khalid SK; Pershbacher J; Makan M; Barzilai B; Goodenberger D Am J Med; 2009 Aug; 122(8):779.e1-9. PubMed ID: 19635281 [TBL] [Abstract][Full Text] [Related]
58. Endoscopic cryotherapy for the treatment of epistaxis due to hereditary hemorrhagic telangiectasia. Kim JY; Oh JH; Kim GT; Kwon JH J Craniofac Surg; 2014; 25(2):e120-2. PubMed ID: 24469376 [TBL] [Abstract][Full Text] [Related]
59. Efficacy and safety of propranolol for epistaxis in hereditary haemorrhagic telangiectasia: retrospective, then prospective study, in a total of 21 patients. Contis A; Gensous N; Viallard JF; Goizet C; Léauté-Labrèze C; Duffau P Clin Otolaryngol; 2017 Aug; 42(4):911-917. PubMed ID: 28032956 [No Abstract] [Full Text] [Related]
60. Morphology and distribution of nasal telangiectasia in HHT-patients with epistaxis. Folz BJ; Wollstein AC; Lippert BM; Werner JA Am J Rhinol; 2005; 19(1):65-70. PubMed ID: 15794077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]